Company Search:
Advanced Search
Sponsored Links
Akers Biosciences Incorporation Company Snapshot
Akers Biosciences Incorporation operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Akers Biosciences Incorporation with three other companies in this sector in the United States: American Cannabis Company Inc (2016 sales of $1.56 million ), Vermillion Inc ($2.64 million of which 100% was Novel Diagnostic Test), and Immunomedics, Inc. ($3.23 million of which 100% was Biopharma Products).

Sales Analysis. During the year ended December of 2016, sales at Akers Biosciences Incorporation were $2.96 million. This is an increase of 40.0% versus 2015, when the company's sales were $2.12 million. Despite this increase, sales are still well below the level achieved in 2014, when Akers Biosciences Incorporation reported sales of $4.43 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Akers Biosciences Incorporation
  Stock Performance Chart for Akers Biosciences Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): .18
(Figures in U.S. Dollars)
1 Week 27.8%   13 Weeks -55.3%  
4 Weeks -82.6%   52 Weeks -85.3%  
Akers Biosciences Incorporation Key Data:
  Ticker: AKER Country: United States
  Exchanges: FRA LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 2,960,912
(Year Ending Jan 2017).
Employees: 28
  Currency: U.S. Dollars Market Cap: 1,819,429
  Fiscal Yr Ends: December Shares Outstanding: 9,920,552
  Share Type: Common Closely Held Shares: 1,699,109
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.